ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : antigenic variants
Clear All
Filter by Field of Research
Medical and Health Sciences (4)
Biochemistry And Cell Biology Not Elsewhere Classified (2)
Humoural immunology and immunochemistry (2)
Medical Parasitology (2)
Allergy (1)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (1)
Cancer Genetics (1)
Cell Physiology (1)
Cellular Interactions (Incl. Adhesion, Matrix, Cell Wall) (1)
Emergency medicine (1)
Endocrinology (1)
Humoural Immunology and Immunochemistry (1)
Medical Genetics (1)
Medical and Health Sciences not elsewhere classified (1)
Medical biochemistry - carbohydrates (1)
Medical physiology not elsewhere classified (1)
Nuclear Medicine (1)
Protein Targeting And Signal Transduction (1)
Rheumatology And Arthritis (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (38)
Filter by Status
Closed (38)
Filter by Scheme
NHMRC Project Grants (29)
NHMRC Postgraduate Scholarships (3)
Project Grants (3)
Early Career Fellowships (2)
NHMRC Research Fellowships (1)
Filter by Country
Australia (1)
Filter by Australian State/Territory
VIC (1)
  • Researchers (0)
  • Funded Activities (38)
  • Organisations (0)
  • Funded Activity

    A Study Of How Murray Valley Encephalitis Virus Causes Disease In Mice

    Funder
    National Health and Medical Research Council
    Funding Amount
    $194,235.00
    More information
    Funded Activity

    Parts Of Human Rotavirus And Target Cells Important In Protection Against Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $411,456.00
    More information
    Funded Activity

    Identification Of Parts Of A Virus That Can Be Used To Protect Children Fron Diarrhoea.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $141,860.00
    More information
    Funded Activity

    The Role Of CD44 Splice Variants In Metastasis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $27,793.00
    More information
    Funded Activity

    Hepatitis B Variation: A Model Of Variation Of Molecular Epidemiology

    Funder
    National Health and Medical Research Council
    Funding Amount
    $210,005.00
    More information
    Funded Activity

    Human Immune Responses To Malaria

    Funder
    National Health and Medical Research Council
    Funding Amount
    $88,234.00
    More information
    Funded Activity

    Functional Evaluation Of BRCA1 & BRCA2 Unclassified Sequence Variants And Identification Of Critical Pathogenic Domains.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $331,312.00
    Summary
    The major genes that predispose to hereditary breast cancer are called BRCA1 and BRCA2. Most mutations in these genes cause the protein product to be truncated and inactive. However there are many families in which such truncating mutations are not found, but instead there are sequence changes that slightly alter the protein product. It is often difficult to predict whether these sequence variants are likely to cause hereditary breast cancer simply by looking at the position and nature of the se .... The major genes that predispose to hereditary breast cancer are called BRCA1 and BRCA2. Most mutations in these genes cause the protein product to be truncated and inactive. However there are many families in which such truncating mutations are not found, but instead there are sequence changes that slightly alter the protein product. It is often difficult to predict whether these sequence variants are likely to cause hereditary breast cancer simply by looking at the position and nature of the sequence change. Consequently, it is not possible to offer informative genetic counselling to these women or their at-risk family members. Assessment of the potential pathogenicity and functional significance of these unclassified sequence variants will be directly useful with regard to the clinical management of these women and their families, and will develop our current understanding of how different domains of these genes contribute to their role as cancer susceptibility genes.
    Read more Read less
    More information
    Funded Activity

    3d Imaging Of Tumours Using Radioactive Tracers

    Funder
    National Health and Medical Research Council
    Funding Amount
    $34,356.00
    More information
    Funded Activity

    Research Fellowship - Grant ID:406617

    Funder
    National Health and Medical Research Council
    Funding Amount
    $329,062.00
    More information
    Funded Activity

    Virulence Determinants In Hepadnavirus Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $377,036.00
    Summary
    The human hepatitis B virus (HBV) is a member of the hepadnavirus family that includes a number of other very similar host-specific viruses. Acute HBV infection can produce extreme variation in disease, ranging from asymptomatic infection, to acute transient hepatitis with jaundice, or fulminant hepatitis leading to liver failure (Hollinger, 1996). The identification of viral genes that affect the severity of disease is a major current goal in medical virology. For example, there is considerable .... The human hepatitis B virus (HBV) is a member of the hepadnavirus family that includes a number of other very similar host-specific viruses. Acute HBV infection can produce extreme variation in disease, ranging from asymptomatic infection, to acute transient hepatitis with jaundice, or fulminant hepatitis leading to liver failure (Hollinger, 1996). The identification of viral genes that affect the severity of disease is a major current goal in medical virology. For example, there is considerable interest in identifying the genes of the influenza genome responsible for high mortality outbreaks; with the human immunodeficiency virus, the virus that causes AIDS, variants deleted in the nef gene region cause a less rapidly progressing infection and have attracted attention as a possible prototype for an attenuated vaccine. We propose to investigate how the different genes of hepadnaviruses affect the course of infection and type of disease produced. Studies will be performed in ducks infected with the duck hepatitis B virus (DHBV) as these animals provide the only model system available in Australia. We will study both experimentally and naturally derived DHBV variants to explore the effects of genetic changes on the outcome of infection. This will enhance our understanding of this virus family and will provide models for comparison with HBV infection. This knowledge may then contribute to our ability to manage and control HBV disease in humans.
    Read more Read less
    More information

    Showing 1-10 of 38 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback